In this episode of "Lab Rats to Unicorns," we're thrilled to spotlight Ritu Shah, the Managing Director at Portal Innovations, whose distinguished career in the biopharma industry spans over two decades. Ritu's unparalleled expertise shines in her role, where she's instrumental in driving growth and enhancing the value of portfolio companies. Specializing in steering early-stage companies towards key milestones and securing funding rounds, her strategic prowess has been key to numerous mergers & acquisitions, company formations, and operations.    

Ritu Shah's journey includes significant roles as a fractional executive, showcasing her versatility through part-time contracted positions as a senior executive with Dimension Inx., head of operations and senior advisor with Reax Biotechnologies, and CEO of ClostraBio. At Portal, she spearheaded the innovative Ex^3 fractional C-suite model for life science clients, marking a significant milestone in her illustrious career. Join us as we explore the intricate dynamics of biotech's fast-evolving landscape, illuminated by Ritu Shah's remarkable insights and achievements.